Shirley, MA, United States of America

Rita Bellis Bortell


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rita Bellis Bortell: Innovator in Cellular Secretion and Protein Modification

Introduction

Rita Bellis Bortell is a distinguished inventor based in Shirley, MA (US). She has made significant contributions to the field of cellular biology, particularly in the areas of cellular secretion and protein modification. With a total of 3 patents, her work has implications for both basic research and therapeutic applications.

Latest Patents

Bortell's latest patents include innovative methods for modulating cellular secretion. One of her notable patents describes methods for identifying novel modulators of cellular secretion that target centrosomal proteins. Another significant patent focuses on using tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins. This method allows for the production of polypeptides with modified activity or stability by replacing an arginine residue capable of being ADP-ribosylated with tryptophan or phenylalanine. These advancements have the potential to enhance immune responses in subjects.

Career Highlights

Throughout her career, Bortell has worked with prestigious institutions such as the University of Massachusetts and the National Institutes of Health, a component of the US Department of Health & Human Services. Her research has contributed to a deeper understanding of cellular mechanisms and has paved the way for new therapeutic strategies.

Collaborations

Bortell has collaborated with notable colleagues, including Joel Moss and Linda Stevens. These partnerships have enriched her research and expanded the impact of her innovations.

Conclusion

Rita Bellis Bortell's work exemplifies the intersection of innovation and scientific research. Her patents and collaborations highlight her commitment to advancing our understanding of cellular processes and developing new therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…